Pattern of rural-urban acquisition of pfcrt T76 allele among Nigerian children with acute uncomplicated Plasmodium falciparum malaria

African Journal of Biotechnology

Volumn 4, Issue 4, 2005, Pages 361-366

  Olukosi, Y A ^a   Iwalokun, B A ^b   Magbagbeola, O A ^a   Akinwande, A I ^a   Adewole, T A ^c   Agomo, P U ^c   Awolola, T S ^c  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b LAGOS STATE UNIVERSITY   (Nigeria)

^c NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

Chloroquine resistance; Nigerian children; Pfcrt T76 mutation; Plasmodium falciparum malaria

Indexed keywords

CHLOROQUINE;

ADOLESCENT; ANALYTIC METHOD; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; NIGERIA; OUTCOMES RESEARCH; PLASMODIUM FALCIPARUM; PREVALENCE; RURAL AREA; SEX DIFFERENCE; URBAN AREA;

PLASMODIUM FALCIPARUM;

EID: 19544390496     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Abdel-Muhsin AM, Mackinnon MJ, Ali E, Nassir el-KA, Suleiman S, Ahmed S, Walliker D, Babiker HA (2004). Evolution of drugresistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan. J. Infect. Dis. 189:1239 - 1244.
2. Abdulahi K, Muhammad S, Manga SB, Tunau IM (2003). Chloroquine resistant Plasmodium falciparum in Sokoto, North Western Nigeria. Afr. J. Biotechnol. 2: 244 - 245.
3. Adagut IS, Warhurst DC (2001). Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria. Parasitology 123(Pt 3): 219 - 224.
4. Afolabi BM, Salako LA, Mafe AG, Ovwigho UB, Rabiu KA, Sanyaolu NO, Ibrahim MM ( 2001). Malaria in the first 6 months of life in urban African infants with anaemia. Am. J. Trop. Med. Hyg. 65: 822 - 827.
5. Angyo IA, Pam SD, Szlachetka R (1996). Clinical pattern and outcome in children with acute severe falciparum malaria at Jos University Teaching Hospital, Nigeria. East Afr. Med. J. 73: 823 - 826.
6. Anita-Obong OE, Alaribe AA, Young MU, Bassy A, Etim BV (1997). Chloroquine-resistant Plasmodium falciparum among children in Calabar, south eastern Nigeria. Trop. Doct. 27: 146-149.
7. CDC (1987). Epidemiologic notes and reports: chloroquine resistant Plasmodium falciparum in West Africa. MMWR. 36: 13 - 14.
8. Chen N, Russell B, Fowler E, Peters J, Cheng Q (2002). Levels of chloroquine resistance in Plasmodium falciparum are determined by loci other than pfcrt and pfmdr1. J. Infect. Dis. 185: 405-407.
9. Cooper KA, Adelekan DA, Esimai AO, Northrop-Clewes CA, Thurnham DI (2002). Lack of influence of red palm oil on severity of malaria infection in pre-school Nigerian children. Trans R Soc. Trop. Med. Hyg. 96: 216 -223.
10. Cravo P, Culleton R, Hunt P, Walliker D, Mackinnon MJ (2001). Antimalarial drugs clear resistant parasites from partially immune hosts. Antimicrobial Agents Chemother. 45: 2897 - 2901.
11. Djimde A, OK Doumbo, JF Cortese, K Kayentao, S Doumbo, Y Diourté, A Dicko, XZ Su, T Nomura, DA Fidock, TE Wellems, CV Plowe (2001). A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:257-263.
12. Dossey G, Kamiya NR, Singh A, Rosenthal PJ (2001). Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J. Infect. Dis. 183: 1417 - 1420.
13. Elesa SO, Adepoju FB, Bayo AA (1993). Rising incidence of cerebral malaria in Lagos, Nigeria: a postmortem study. East Afr. Med. J. 70: 302 - 306.
14. Ezedinachi ENU, Egwu IN, Nwangwa MA, Charles IO (1997). Perception of malaria infection in two rural communities in Nigeria. Intl. Q. Community. Health Educ. 16: 257 - 270.
15. Ezedinachi ENU, Ekanem OJ, Chuckwuani CM, Meremikwu MM, Ojar EA, Alaribe AA, Umotong AB, Haller L (1999). Efficacy and tolerability of a low-dose melfloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a populatyion with multiple drug-resistant Plasmodium falciparum. Am. J. Trop. Med. Hyg. 61: 114 - 119.
16. Fidock DA, T Nomura, AK Talley, RA Cooper, SM Dzekunov, MT Ferdig, LM Ursos, AB Sidhu, B Naude, KW Deitsch, XZ Su, JC Wootton, PD Roepe, TE Wellems (2000). Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell. 6: 861 - 871.
17. Happi CT, Gbotosho GO, Sowunmi A, Falade CO, Akinboye DO, Gerena I, Kyle DE, Milhous W, Wirth DF, Oduola AMJ (2004). Molecular analysis of plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. Am. J. Trop. Med. Hyg. 70: 20-26.
18. Happi TC, Thomas SM, Gbotosho CO, Falade CO, Akinboye DO, Gerena L, Hudson T, Sowumi A, Kyle DE, Milhous W, Wirth DF, Oduola AMJ (2003). Point mutation in pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Ann. Trop. Med. Hyg. 97: 439 - 451.
19. Kallwarg J, Harinasuta J (1992). Overview: clinical pharmacology of antimalarials. Southeast Asian. J. Trop. Med. Public Health Suppl. 4: 95 - 101.
20. Labbe AC, Patel S, Crandall I, Kain KC (2003). A molecular surveillance system for global patterns of drug resistance in imported malaria. Emerg Infect Dis. 9(1):33-6
21. *Lege-Oguntoye L, Abua JU, Werblinska B, Ogala WN, Slotboom AB, Olurinola PF (1989). Chloroquine resistance of Plasmodium falciparum in semi-immune children in Zaria, northern Nigeria. Trans R Soc. Trop. Med. Hyg. 83: 599 - 601.
22. May J, Meyer CG (2003). Association of plasmodium falciparum chloroquine resistance transporter variant t76 with age-related plasma chloroquine levels. Am. J. Trop. Med. Hyg. 68: 143-146.
23. Metzger A, Mukasa G, Shankar AH, Ndeezi G, Melikian G, Semba RD (2001). Antioxidant status and acute malaria in children in Kampala, Uganda. Am. J. Trop. Med. Hyg. 65: 115 - 119.
24. Mockenhaupt FP, May J, Bergovist Y, Ademowo OG, Olumese PE, Falusi AG, Grobterlinden L, Meyer CG, Bienzzee U (2000). Concentrations of chloroquine and malaria parasites in blood in Nigerian children. Antimicrob. Agents Chemother. 44: 835 - 839.
25. nd edition. Lindoz publisher. Lagos, Nig. pp. 32 - 38.
26. Okonkwo CA, Coker HA, Agomo PU, Ogunbanwo JA, Mafe AG, Agomo CO, Afolabi BM (1999). Effect of chlorpheniramine on the pharmacokinetics of and response to chloroquine of Nigerian children with falciparum malaria. Trans R Soc. Trop. Med. Hyg. 93: 306 -311.
27. Olumese PE, Amodu OK, Bjorkman A, Adeyemo AA, Gbadegesin RA, Walker O (2002). Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans. R Soc. Trop. Med. Hyg. 96: 418 - 420.
28. Ramson-Kuti, O (1989). Guiudlines for Malaria Control. Lagos, Nigeria. Federal Ministry of Health
29. Ranford CL, J Taylor, T Umasunthar, LH Taylor, HA Babiker, B Lell, OJ Schmidt, LG Lehman, D. Walliker, PG Kremsner (1997). Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91: 719-724.
30. Ranjit MR, Das A, Chhotray GP, Das BP, Das BN, Acharya AS (2004). The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection. Trop. Med. Intl. Health 9: 857 - 861.
31. Salako LA, Ajayi FO, Sowunmi A, Walker O (1990). Malaria in Nigeria. A revisit. Annals Trop. Med. Parasitol. 84: 435 - 445.
32. Salako LA, Brieger WR, Afolabi BM, Umeh RE, Agomo PU, Asa S, Adeneye AK, Nwankwo BO, Akinlade CO (2001). Treatment of childhood fevers and other illnesses in three rural Nigerian communities. J. Trop. Pediatr. 47: 230 - 238.
33. Serghides L, Kain KC (2002). Mechanism of protection induced by vitamin A in falciparum malaria. Lancet 359:1404-1446.
34. Shankar AH, Genton B, Semba RD, Baisor M, Paino J, Tamja S, Adiguma T, Wu L, Rare L, Tielsch JM, Alpers MP, West KP Jr. (1999). Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial. Lancet. 354: 203 - 209.
35. Snounou G, Viriyakasol S, Zhu XP, Jarra W, Pinheirro L, Rosaro VE, Thaitong S, Brown, KN (1993). High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 61: 315 - 320.
36. Tett S, Day R, Cutler D (1996). Hydroxychloroquine relative bioavailability: within subjects reproducibility. Br. J. Clin. Pharmacol. 41: 244 - 246.
37. Thomas SM, Ndir O, Dieng T, Mboup S, Wypij D, Maguire JH, Wirth DF (2002). In vitro chloroquine susceptibility and pcr analysis of pfcrt and pfmdr1 polymorphisms in plasmodium falciparum isolates from Senegal. Am. J. Trop. Med. Hyg. 66: 474 - 480.
38. Tinto H, Quedraogo JB, Erhart A, Van Overmeir C, Dujardiin JC, Van Marck E, Guijemde TR, D'Alessandro U (2003). Relationship between the pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro / in vivo chloroquine resistance in Burkina Faso, West Africa. Infect. Genet. Evol. 3: 287 - 292.
39. Van den Broek IV, van der Wardt S, Talukder L, Chakma S, Brockman A, Nair S, Anderson TC (2004). Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh. Trop. Med. Intl. Health 9: 680 -687.
40. Waller KL, Muhle RA, Ursos LM, Horrocks P, Verdier-Pinard, D, Sidhu AS, Fujioka H, Roepe PD, Fidock, DA (2001). Chloroquine resistance modulated in vitro by expression levels of the Plasmodium falciparum chloroquine resistance transporter. J. Biol. Chem. 278: 33593 - 33601.
41. Warhurst DC, Wil.liams JE (1996). Laboratory diagnosis of malaria. J. Clin. Pathol. 49: 533 - 538.